Acadia Pharmaceuticals buy BiotechBee
Start price
03.01.23
/
60%
€15.65
Target price
31.12.25
€22.00
Performance (%)
23.98%
End price
05.05.23
€19.40
Summary
This prediction ended on 05.05.23 with a price of €19.40. The BUY prediction by BiotechBee finished with a performance of 23.98%. BiotechBee has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Acadia Pharmaceuticals | 11.075% | 11.075% | -30.477% |
iShares Core DAX® | -0.079% | -3.039% | 13.992% |
iShares Nasdaq 100 | 0.247% | 6.421% | 36.232% |
iShares Nikkei 225® | 1.918% | 0.675% | 10.784% |
iShares S&P 500 | 0.146% | 4.708% | 29.832% |
According to BiotechBee what are the pros and cons of Acadia Pharmaceuticals for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Acadia Pharmaceuticals diskutieren
Buy mit Kursziel 22,0
In the thread Trading Acadia Pharmaceuticals
Buy beendet